Treatment of Myelofibrosis: Old and New Strategies

Myelofibrosis (MF) is a BCR-ABL1–negative myeloproliferative neoplasm that is mainly characterised by reactive bone marrow fibrosis, extramedullary haematopoiesis, anaemia, hepatosplenomegaly, constitutional symptoms, leukaemic progression, and shortened survival. As such, this malignancy is still o...

Descripción completa

Detalles Bibliográficos
Autores principales: Iurlo, Alessandra, Cattaneo, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428134/
https://www.ncbi.nlm.nih.gov/pubmed/28579852
http://dx.doi.org/10.1177/1179545X17695233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428134/
https://www.ncbi.nlm.nih.gov/pubmed/28579852
http://dx.doi.org/10.1177/1179545X17695233

Ejemplares similares